These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 23828162)

  • 1. Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients.
    Yuan J; Guo Q; Qureshi AR; Anderstam B; Eriksson M; Heimbürger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2013 Sep; 28(9):2356-63. PubMed ID: 23828162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of VEGF and its receptors sVEGFR-1 and -2 with cardiovascular disease and survival in prevalent haemodialysis patients.
    Guo Q; Carrero JJ; Yu X; Bárány P; Qureshi AR; Eriksson M; Anderstam B; Chmielewski M; Heimbürger O; Stenvinkel P; Lindholm B; Axelsson J
    Nephrol Dial Transplant; 2009 Nov; 24(11):3468-73. PubMed ID: 19561151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia.
    Wierzbowska A; Robak T; Wrzesień-Kuś A; Krawczyńska A; Lech-Marańda E; Urbańska-Ryś H
    Eur Cytokine Netw; 2003; 14(3):149-53. PubMed ID: 14656688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
    Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
    Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition.
    de Mutsert R; Grootendorst DC; Indemans F; Boeschoten EW; Krediet RT; Dekker FW;
    J Ren Nutr; 2009 Mar; 19(2):127-35. PubMed ID: 19218039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
    Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced serum vascular endothelial growth factor receptor-2 (sVEGFR-2) and sVEGFR-1 levels in gastric cancer patients.
    Kikuchi S; Obata Y; Yagyu K; Lin Y; Nakajima T; Kobayashi O; Kikuichi M; Ushijima R; Kurosawa M; Ueda J
    Cancer Sci; 2011 Apr; 102(4):866-9. PubMed ID: 21219538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients.
    Metry G; Stenvinkel P; Qureshi AR; Carrero JJ; Yilmaz MI; Bárány P; Snaedal S; Heimbürger O; Lindholm B; Suliman ME
    Eur J Clin Invest; 2008 Nov; 38(11):804-11. PubMed ID: 19021697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S; Heimbürger O; Qureshi AR; Danielsson A; Wikström B; Fellström B; Fehrman-Ekholm I; Carrero JJ; Alvestrand A; Stenvinkel P; Bárány P
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaemia and resistance to erythropoiesis-stimulating agents as prognostic factors in haemodialysis patients: results from the RISCAVID study.
    Panichi V; Rosati A; Bigazzi R; Paoletti S; Mantuano E; Beati S; Marchetti V; Bernabini G; Grazi G; Rizza GM; Migliori M; Giusti R; Lippi A; Casani A; Barsotti G; Tetta C;
    Nephrol Dial Transplant; 2011 Aug; 26(8):2641-8. PubMed ID: 21325348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
    Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
    Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease.
    Breit SN; Carrero JJ; Tsai VW; Yagoutifam N; Luo W; Kuffner T; Bauskin AR; Wu L; Jiang L; Barany P; Heimburger O; Murikami MA; Apple FS; Marquis CP; Macia L; Lin S; Sainsbury A; Herzog H; Law M; Stenvinkel P; Brown DA
    Nephrol Dial Transplant; 2012 Jan; 27(1):70-5. PubMed ID: 21940482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.
    Leinig C; Pecoits-Filho R; Nascimento MM; Gonçalves S; Riella MC; Martins C
    J Ren Nutr; 2008 Sep; 18(5):424-9. PubMed ID: 18721737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiopoietin-2 levels predict mortality in CKD patients.
    David S; John SG; Jefferies HJ; Sigrist MK; Kümpers P; Kielstein JT; Haller H; McIntyre CW
    Nephrol Dial Transplant; 2012 May; 27(5):1867-72. PubMed ID: 21976741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis.
    Koch M; Kohnle M; Trapp R; Haastert B; Rump LC; Aker S
    Nephrol Dial Transplant; 2012 Jan; 27(1):375-80. PubMed ID: 21622993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased IGF-1 levels potentiate association of inflammation with all-cause and cardiovascular mortality in prevalent hemodialysis patients.
    Beberashvili I; Sinuani I; Azar A; Kadoshi H; Shapiro G; Feldman L; Sandbank J; Averbukh Z
    Growth Horm IGF Res; 2013 Dec; 23(6):209-14. PubMed ID: 23958273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentration of von Willebrand factor predicts mortality in patients on chronic renal replacement therapy.
    Péquériaux NC; Fijnheer R; Gemen EF; Barendrecht AD; Dekker FW; Krediet RT; Beutler JJ; Boeschoten EW; Roest M
    Nephrol Dial Transplant; 2012 Jun; 27(6):2452-7. PubMed ID: 22189209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the clinical conditions at dialysis initiation on mortality in incident haemodialysis patients: a national cohort study in Taiwan.
    Hwang SJ; Yang WC; Lin MY; Mau LW; Chen HC;
    Nephrol Dial Transplant; 2010 Aug; 25(8):2616-24. PubMed ID: 20519231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients.
    Liabeuf S; Barreto DV; Barreto FC; Chasseraud M; Brazier M; Choukroun G; Kamel S; Massy ZA
    Nephrol Dial Transplant; 2010 Aug; 25(8):2596-602. PubMed ID: 20190248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.